Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersNo recent work listed

L. Bengt van Rijssen

Matched on ORCID iD 0000-0001-5918-1772; OpenAlex author ID A5020798051. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
86
Papers, trials and grants by year

2016: 2 papers · 2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: 2 papers · 2021: none · 2022: 1 paper

Papers 10

  1. Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI): pros… Co-author DOI 10.1007/s00423-022-02653-y↗
  2. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classificati… Co-author DOI 10.1038/s41598-019-56826-9↗
  3. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled t… Co-author DOI 10.1186/s13063-020-4180-z↗
  4. Added value of intra-operative ultrasound to determine the resectability of locally advanced pancreatic cancer following FOLFIRINOX chemotherapy (IMAGE): a pro… Co-author DOI 10.1016/j.hpb.2019.02.017↗
  5. Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care Providers. Co-author DOI 10.1097/sla.0000000000002633↗
  6. Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease. First author DOI 10.1016/s1470-2045(18)30098-6↗
  7. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy. Co-author DOI 10.1038/s41389-018-0096-9↗
  8. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. Co-author DOI 10.1016/j.hpb.2017.06.010↗
  9. Recent Advances in Pancreatic Cancer Surgery of Relevance to the Practicing Pathologist. Co-author DOI 10.1016/j.path.2016.05.002↗
  10. Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-016-5373-2↗

Closest collaborators

The 25 strongest of 86 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marc G. Besselink · 9 shared papers, 2016–2022 · strength 0.62
  2. Hanneke W.M. van Laarhoven · 6 shared papers, 2018–2022 · strength 0.46
  3. Johanna W. Wilmink · 5 shared papers, 2016–2022 · strength 0.38
  4. Ignace H. J. T. de Hingh · 3 shared papers, 2017–2022 · strength 0.24
  5. Izaak Quintus Molenaar · 4 shared papers, 2016–2019 · strength 0.24
  6. Krijn P. van Lienden · 2 shared papers, 2019–2022 · strength 0.20
  7. Eran van Veldhuisen · 2 shared papers, 2019–2022 · strength 0.20
  8. Marieke S. Walma · 3 shared papers, 2016–2019 · strength 0.19
  9. Hjalmar C. van Santvoort · 3 shared papers, 2016–2019 · strength 0.18
  10. Hanneke W. Wilmink · 2 shared papers, 2018–2020 · strength 0.14
  11. Veronique L. Veenstra · 2 shared papers, 2018–2020 · strength 0.14
  12. Frederike Dijk · 2 shared papers, 2018–2020 · strength 0.14
  13. Helene Damhofer · 2 shared papers, 2018–2020 · strength 0.14
  14. Maarten F. Bijlsma · 2 shared papers, 2018–2020 · strength 0.14
  15. Nadia Haj Mohammad · 2 shared papers, 2016–2019 · strength 0.13
  16. Johanna A.M.G. Tol · 2 shared papers, 2016–2020 · strength 0.13
  17. Joanne Verheij · 2 shared papers, 2016–2020 · strength 0.13
  18. Remy Klaassen · 1 shared paper, 2022 · strength 0.12
  19. Leonard W. F. Seelen · 1 shared paper, 2022 · strength 0.12
  20. Aart Johannes Nederveen · 1 shared paper, 2022 · strength 0.12
  21. Oliver J. Gurney‐Champion · 1 shared paper, 2022 · strength 0.12
  22. Thomas F. Stoop · 1 shared paper, 2022 · strength 0.12
  23. Hendrik A. Marsman · 1 shared paper, 2022 · strength 0.12
  24. Christopher Lee Wolfgang · 2 shared papers, 2017–2019 · strength 0.12
  25. Steffi J. E. Rombouts · 2 shared papers, 2016 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.